Selected research
Industry Research
GPCR Screening Service Industry Research Report 2026
Market perspective
The global GPCR Screening Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the GPCR Screening Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the GPCR Screening Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the GPCR Screening Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of GPCR Screening Service include Eurofins Discovery, Charles River Laboratories International, Inc., Reaction Biology Corporation, Sygnature Discovery Limited, Evotec SE, Multispan, Inc., Pharmaron Beijing Co., Ltd., PharmaLegacy Laboratories and BioAscent Discovery Limited, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global GPCR Screening Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to GPCR Screening Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
GPCR Screening Service Market by Company
Eurofins Discovery
Charles River Laboratories International, Inc.
Reaction Biology Corporation
Sygnature Discovery Limited
Evotec SE
Multispan, Inc.
Pharmaron Beijing Co., Ltd.
PharmaLegacy Laboratories
BioAscent Discovery Limited
Creative Biogene
Creative Bioarray
ICE Bioscience
Shanghai Jinsirui Vigorous Biotechnology Co., Ltd.
Promega Corporation
Proteros biostructures GmbH
Aragen Life Sciences
BPS Bioscience, Inc.
Revvity, Inc.
Genscript Biotech Corporation
Beijing Abace Biotechnology Co., Ltd.
MedChemExpress LLC
BrainVTA (Wuhan) Co., Ltd.
Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd.
Penn State GPCR Assay Service Center
Celtarys Research
GPCR Screening Service Segment by Type
Gs Pathway Screening
Gi/o Pathway Screening
Gq Pathway Screening
G12/13 Pathway Screening
GPCR Screening Service Segment by Application
Pharmaceuticals
Disease Treatment
Research
Other
GPCR Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GPCR Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GPCR Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GPCR Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of GPCR Screening Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global GPCR Screening Service Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global GPCR Screening Service Revenue Market Share by Type (2021-2026)
Table 7. Global GPCR Screening Service Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global GPCR Screening Service Revenue Market Share by Type (2027-2032)
Table 9. Global GPCR Screening Service Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global GPCR Screening Service Revenue Market Share by Application (2021-2026)
Table 11. Global GPCR Screening Service Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global GPCR Screening Service Revenue Market Share by Application (2027-2032)
Table 13. Global GPCR Screening Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global GPCR Screening Service Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global GPCR Screening Service Market Share by Region (2021-2026)
Table 16. Global GPCR Screening Service Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global GPCR Screening Service Market Share by Region (2027-2032)
Table 18. GPCR Screening Service Industry Trends
Table 19. GPCR Screening Service Industry Drivers
Table 20. GPCR Screening Service Industry Opportunities and Challenges
Table 21. GPCR Screening Service Market Restraints
Table 22. Global Top GPCR Screening Service Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global GPCR Screening Service Revenue Market Share by Players (2021-2026)
Table 24. Global GPCR Screening Service Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of GPCR Screening Service, Headquarters and Area Served
Table 26. Global GPCR Screening Service Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global GPCR Screening Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America GPCR Screening Service Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America GPCR Screening Service Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe GPCR Screening Service Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe GPCR Screening Service Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific GPCR Screening Service Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific GPCR Screening Service Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America GPCR Screening Service Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America GPCR Screening Service Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa GPCR Screening Service Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa GPCR Screening Service Market Size by Country (2027-2032) & (US$ Million)
Table 45. Eurofins Discovery Company Information
Table 46. Eurofins Discovery Business Overview
Table 47. Eurofins Discovery Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 48. Eurofins Discovery GPCR Screening Service Product Portfolio
Table 49. Eurofins Discovery Recent Developments
Table 50. Charles River Laboratories International, Inc. Company Information
Table 51. Charles River Laboratories International, Inc. Business Overview
Table 52. Charles River Laboratories International, Inc. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 53. Charles River Laboratories International, Inc. GPCR Screening Service Product Portfolio
Table 54. Charles River Laboratories International, Inc. Recent Developments
Table 55. Reaction Biology Corporation Company Information
Table 56. Reaction Biology Corporation Business Overview
Table 57. Reaction Biology Corporation Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 58. Reaction Biology Corporation GPCR Screening Service Product Portfolio
Table 59. Reaction Biology Corporation Recent Developments
Table 60. Sygnature Discovery Limited Company Information
Table 61. Sygnature Discovery Limited Business Overview
Table 62. Sygnature Discovery Limited Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 63. Sygnature Discovery Limited GPCR Screening Service Product Portfolio
Table 64. Sygnature Discovery Limited Recent Developments
Table 65. Evotec SE Company Information
Table 66. Evotec SE Business Overview
Table 67. Evotec SE Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 68. Evotec SE GPCR Screening Service Product Portfolio
Table 69. Evotec SE Recent Developments
Table 70. Multispan, Inc. Company Information
Table 71. Multispan, Inc. Business Overview
Table 72. Multispan, Inc. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 73. Multispan, Inc. GPCR Screening Service Product Portfolio
Table 74. Multispan, Inc. Recent Developments
Table 75. Pharmaron Beijing Co., Ltd. Company Information
Table 76. Pharmaron Beijing Co., Ltd. Business Overview
Table 77. Pharmaron Beijing Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 78. Pharmaron Beijing Co., Ltd. GPCR Screening Service Product Portfolio
Table 79. Pharmaron Beijing Co., Ltd. Recent Developments
Table 80. PharmaLegacy Laboratories Company Information
Table 81. PharmaLegacy Laboratories Business Overview
Table 82. PharmaLegacy Laboratories Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 83. PharmaLegacy Laboratories GPCR Screening Service Product Portfolio
Table 84. PharmaLegacy Laboratories Recent Developments
Table 85. BioAscent Discovery Limited Company Information
Table 86. BioAscent Discovery Limited Business Overview
Table 87. BioAscent Discovery Limited Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 88. BioAscent Discovery Limited GPCR Screening Service Product Portfolio
Table 89. BioAscent Discovery Limited Recent Developments
Table 90. Creative Biogene Company Information
Table 91. Creative Biogene Business Overview
Table 92. Creative Biogene Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 93. Creative Biogene GPCR Screening Service Product Portfolio
Table 94. Creative Biogene Recent Developments
Table 95. Creative Bioarray Company Information
Table 96. Creative Bioarray Business Overview
Table 97. Creative Bioarray Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 98. Creative Bioarray GPCR Screening Service Product Portfolio
Table 99. Creative Bioarray Recent Developments
Table 100. ICE Bioscience Company Information
Table 101. ICE Bioscience Business Overview
Table 102. ICE Bioscience Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 103. ICE Bioscience GPCR Screening Service Product Portfolio
Table 104. ICE Bioscience Recent Developments
Table 105. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Company Information
Table 106. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Business Overview
Table 107. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 108. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. GPCR Screening Service Product Portfolio
Table 109. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Recent Developments
Table 110. Promega Corporation Company Information
Table 111. Promega Corporation Business Overview
Table 112. Promega Corporation Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 113. Promega Corporation GPCR Screening Service Product Portfolio
Table 114. Promega Corporation Recent Developments
Table 115. Proteros biostructures GmbH Company Information
Table 116. Proteros biostructures GmbH Business Overview
Table 117. Proteros biostructures GmbH Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 118. Proteros biostructures GmbH GPCR Screening Service Product Portfolio
Table 119. Proteros biostructures GmbH Recent Developments
Table 120. Aragen Life Sciences Company Information
Table 121. Aragen Life Sciences Business Overview
Table 122. Aragen Life Sciences Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 123. Aragen Life Sciences GPCR Screening Service Product Portfolio
Table 124. Aragen Life Sciences Recent Developments
Table 125. BPS Bioscience, Inc. Company Information
Table 126. BPS Bioscience, Inc. Business Overview
Table 127. BPS Bioscience, Inc. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 128. BPS Bioscience, Inc. GPCR Screening Service Product Portfolio
Table 129. BPS Bioscience, Inc. Recent Developments
Table 130. Revvity, Inc. Company Information
Table 131. Revvity, Inc. Business Overview
Table 132. Revvity, Inc. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 133. Revvity, Inc. GPCR Screening Service Product Portfolio
Table 134. Revvity, Inc. Recent Developments
Table 135. Genscript Biotech Corporation Company Information
Table 136. Genscript Biotech Corporation Business Overview
Table 137. Genscript Biotech Corporation Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 138. Genscript Biotech Corporation GPCR Screening Service Product Portfolio
Table 139. Genscript Biotech Corporation Recent Developments
Table 140. Beijing Abace Biotechnology Co., Ltd. Company Information
Table 141. Beijing Abace Biotechnology Co., Ltd. Business Overview
Table 142. Beijing Abace Biotechnology Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 143. Beijing Abace Biotechnology Co., Ltd. GPCR Screening Service Product Portfolio
Table 144. Beijing Abace Biotechnology Co., Ltd. Recent Developments
Table 145. MedChemExpress LLC Company Information
Table 146. MedChemExpress LLC Business Overview
Table 147. MedChemExpress LLC Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 148. MedChemExpress LLC GPCR Screening Service Product Portfolio
Table 149. MedChemExpress LLC Recent Developments
Table 150. BrainVTA (Wuhan) Co., Ltd. Company Information
Table 151. BrainVTA (Wuhan) Co., Ltd. Business Overview
Table 152. BrainVTA (Wuhan) Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 153. BrainVTA (Wuhan) Co., Ltd. GPCR Screening Service Product Portfolio
Table 154. BrainVTA (Wuhan) Co., Ltd. Recent Developments
Table 155. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Company Information
Table 156. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Business Overview
Table 157. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 158. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. GPCR Screening Service Product Portfolio
Table 159. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Recent Developments
Table 160. Penn State GPCR Assay Service Center Company Information
Table 161. Penn State GPCR Assay Service Center Business Overview
Table 162. Penn State GPCR Assay Service Center Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 163. Penn State GPCR Assay Service Center GPCR Screening Service Product Portfolio
Table 164. Penn State GPCR Assay Service Center Recent Developments
Table 165. Celtarys Research Company Information
Table 166. Celtarys Research Business Overview
Table 167. Celtarys Research Revenue in GPCR Screening Service Business (2021-2026) & (US$ Million)
Table 168. Celtarys Research GPCR Screening Service Product Portfolio
Table 169. Celtarys Research Recent Developments
Table 170. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. GPCR Screening Service Product Image
Figure 5. Global GPCR Screening Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global GPCR Screening Service Market Share by Type: 2025 VS 2032
Figure 7. Gs Pathway Screening Product
Figure 8. Gi/o Pathway Screening Product
Figure 9. Gq Pathway Screening Product
Figure 10. G12/13 Pathway Screening Product
Figure 11. Global GPCR Screening Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 12. Global GPCR Screening Service Market Share by Application: 2025 VS 2032
Figure 13. Pharmaceuticals Product
Figure 14. Disease Treatment Product
Figure 15. Research Product
Figure 16. Other Product
Figure 17. Global GPCR Screening Service Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global GPCR Screening Service Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global GPCR Screening Service Market Share by Region: 2025 VS 2032
Figure 20. Global GPCR Screening Service Market Share by Players in 2025
Figure 21. Global GPCR Screening Service Manufacturers Established Date
Figure 22. Global Top 5 and 10 GPCR Screening Service Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America GPCR Screening Service Market Share by Country (2021-2032)
Figure 26. United States GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico GPCR Screening Service Market Share by Country (2021-2032)
Figure 29. Europe GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe GPCR Screening Service Market Share by Country (2021-2032)
Figure 31. Germany GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific GPCR Screening Service Market Share by Country (2021-2032)
Figure 41. China GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India GPCR Screening Service Market Share by Country (2021-2032)
Figure 46. Australia GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America GPCR Screening Service Market Share by Country (2021-2032)
Figure 51. Brazil GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru GPCR Screening Service Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Eurofins Discovery Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 57. Charles River Laboratories International, Inc. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 58. Reaction Biology Corporation Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 59. Sygnature Discovery Limited Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 60. Evotec SE Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 61. Multispan, Inc. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 62. Pharmaron Beijing Co., Ltd. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 63. PharmaLegacy Laboratories Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 64. BioAscent Discovery Limited Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 65. Creative Biogene Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 66. Creative Bioarray Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 67. ICE Bioscience Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 68. Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 69. Promega Corporation Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 70. Proteros biostructures GmbH Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 71. Aragen Life Sciences Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 72. BPS Bioscience, Inc. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 73. Revvity, Inc. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 74. Genscript Biotech Corporation Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 75. Beijing Abace Biotechnology Co., Ltd. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 76. MedChemExpress LLC Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 77. BrainVTA (Wuhan) Co., Ltd. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 78. Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 79. Penn State GPCR Assay Service Center Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Figure 80. Celtarys Research Revenue Growth Rate in GPCR Screening Service Business (2021-2026)
Scope & coverage.
Types
- Gs Pathway Screening
- Gi/o Pathway Screening
- Gq Pathway Screening
- G12/13 Pathway Screening
Applications
- Pharmaceuticals
- Disease Treatment
- Research
- Other
Companies covered
- Eurofins Discovery
- Charles River Laboratories International, Inc.
- Reaction Biology Corporation
- Sygnature Discovery Limited
- Evotec SE
- Multispan, Inc.
- Pharmaron Beijing Co., Ltd.
- PharmaLegacy Laboratories
- BioAscent Discovery Limited
- Creative Biogene
- Creative Bioarray
- ICE Bioscience
- Shanghai Jinsirui Vigorous Biotechnology Co., Ltd.
- Promega Corporation
- Proteros biostructures GmbH
- Aragen Life Sciences
- BPS Bioscience, Inc.
- Revvity, Inc.
- Genscript Biotech Corporation
- Beijing Abace Biotechnology Co., Ltd.
- MedChemExpress LLC
- BrainVTA (Wuhan) Co., Ltd.
- Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd.
- Penn State GPCR Assay Service Center
- Celtarys Research
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 GPCR Screening Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Gs Pathway Screening
- 2.2.3 Gi/o Pathway Screening
- 2.2.4 Gq Pathway Screening
- 2.2.5 G12/13 Pathway Screening
- 2.3 GPCR Screening Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals
- 2.3.3 Disease Treatment
- 2.3.4 Research
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 GPCR Screening Service Breakdown Data by Type
- 3.1 Global GPCR Screening Service Historic Market Size by Type (2021-2026)
- 3.2 Global GPCR Screening Service Forecasted Market Size by Type (2027-2032)
4 GPCR Screening Service Breakdown Data by Application
- 4.1 Global GPCR Screening Service Historic Market Size by Application (2021-2026)
- 4.2 Global GPCR Screening Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global GPCR Screening Service Market Perspective (2021-2032)
- 5.2 Global GPCR Screening Service Growth Trends by Region
- 5.2.1 Global GPCR Screening Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 GPCR Screening Service Historic Market Size by Region (2021-2026)
- 5.2.3 GPCR Screening Service Forecasted Market Size by Region (2027-2032)
- 5.3 GPCR Screening Service Market Dynamics
- 5.3.1 GPCR Screening Service Industry Trends
- 5.3.2 GPCR Screening Service Market Drivers
- 5.3.3 GPCR Screening Service Market Challenges
- 5.3.4 GPCR Screening Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top GPCR Screening Service Players by Revenue
- 6.1.1 Global Top GPCR Screening Service Players by Revenue (2021-2026)
- 6.1.2 Global GPCR Screening Service Revenue Market Share by Players (2021-2026)
- 6.2 Global GPCR Screening Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of GPCR Screening Service Head Office and Area Served
- 6.4 Global GPCR Screening Service Players, Product Type & Application
- 6.5 Global GPCR Screening Service Manufacturers Established Date
- 6.6 Global GPCR Screening Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America GPCR Screening Service Market Size (2021-2032)
- 7.2 North America GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America GPCR Screening Service Market Size by Country (2021-2026)
- 7.4 North America GPCR Screening Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe GPCR Screening Service Market Size (2021-2032)
- 8.2 Europe GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe GPCR Screening Service Market Size by Country (2021-2026)
- 8.4 Europe GPCR Screening Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific GPCR Screening Service Market Size (2021-2032)
- 9.2 Asia-Pacific GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific GPCR Screening Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific GPCR Screening Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America GPCR Screening Service Market Size (2021-2032)
- 10.2 South America GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America GPCR Screening Service Market Size by Country (2021-2026)
- 10.4 South America GPCR Screening Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa GPCR Screening Service Market Size (2021-2032)
- 11.2 Middle East & Africa GPCR Screening Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa GPCR Screening Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa GPCR Screening Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Discovery
- 12.1.1 Eurofins Discovery Company Information
- 12.1.2 Eurofins Discovery Business Overview
- 12.1.3 Eurofins Discovery Revenue in GPCR Screening Service Business (2021-2026)
- 12.1.4 Eurofins Discovery GPCR Screening Service Product Portfolio
- 12.1.5 Eurofins Discovery Recent Developments
- 12.2 Charles River Laboratories International, Inc.
- 12.2.1 Charles River Laboratories International, Inc. Company Information
- 12.2.2 Charles River Laboratories International, Inc. Business Overview
- 12.2.3 Charles River Laboratories International, Inc. Revenue in GPCR Screening Service Business (2021-2026)
- 12.2.4 Charles River Laboratories International, Inc. GPCR Screening Service Product Portfolio
- 12.2.5 Charles River Laboratories International, Inc. Recent Developments
- 12.3 Reaction Biology Corporation
- 12.3.1 Reaction Biology Corporation Company Information
- 12.3.2 Reaction Biology Corporation Business Overview
- 12.3.3 Reaction Biology Corporation Revenue in GPCR Screening Service Business (2021-2026)
- 12.3.4 Reaction Biology Corporation GPCR Screening Service Product Portfolio
- 12.3.5 Reaction Biology Corporation Recent Developments
- 12.4 Sygnature Discovery Limited
- 12.4.1 Sygnature Discovery Limited Company Information
- 12.4.2 Sygnature Discovery Limited Business Overview
- 12.4.3 Sygnature Discovery Limited Revenue in GPCR Screening Service Business (2021-2026)
- 12.4.4 Sygnature Discovery Limited GPCR Screening Service Product Portfolio
- 12.4.5 Sygnature Discovery Limited Recent Developments
- 12.5 Evotec SE
- 12.5.1 Evotec SE Company Information
- 12.5.2 Evotec SE Business Overview
- 12.5.3 Evotec SE Revenue in GPCR Screening Service Business (2021-2026)
- 12.5.4 Evotec SE GPCR Screening Service Product Portfolio
- 12.5.5 Evotec SE Recent Developments
- 12.6 Multispan, Inc.
- 12.6.1 Multispan, Inc. Company Information
- 12.6.2 Multispan, Inc. Business Overview
- 12.6.3 Multispan, Inc. Revenue in GPCR Screening Service Business (2021-2026)
- 12.6.4 Multispan, Inc. GPCR Screening Service Product Portfolio
- 12.6.5 Multispan, Inc. Recent Developments
- 12.7 Pharmaron Beijing Co., Ltd.
- 12.7.1 Pharmaron Beijing Co., Ltd. Company Information
- 12.7.2 Pharmaron Beijing Co., Ltd. Business Overview
- 12.7.3 Pharmaron Beijing Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026)
- 12.7.4 Pharmaron Beijing Co., Ltd. GPCR Screening Service Product Portfolio
- 12.7.5 Pharmaron Beijing Co., Ltd. Recent Developments
- 12.8 PharmaLegacy Laboratories
- 12.8.1 PharmaLegacy Laboratories Company Information
- 12.8.2 PharmaLegacy Laboratories Business Overview
- 12.8.3 PharmaLegacy Laboratories Revenue in GPCR Screening Service Business (2021-2026)
- 12.8.4 PharmaLegacy Laboratories GPCR Screening Service Product Portfolio
- 12.8.5 PharmaLegacy Laboratories Recent Developments
- 12.9 BioAscent Discovery Limited
- 12.9.1 BioAscent Discovery Limited Company Information
- 12.9.2 BioAscent Discovery Limited Business Overview
- 12.9.3 BioAscent Discovery Limited Revenue in GPCR Screening Service Business (2021-2026)
- 12.9.4 BioAscent Discovery Limited GPCR Screening Service Product Portfolio
- 12.9.5 BioAscent Discovery Limited Recent Developments
- 12.10 Creative Biogene
- 12.10.1 Creative Biogene Company Information
- 12.10.2 Creative Biogene Business Overview
- 12.10.3 Creative Biogene Revenue in GPCR Screening Service Business (2021-2026)
- 12.10.4 Creative Biogene GPCR Screening Service Product Portfolio
- 12.10.5 Creative Biogene Recent Developments
- 12.11 Creative Bioarray
- 12.11.1 Creative Bioarray Company Information
- 12.11.2 Creative Bioarray Business Overview
- 12.11.3 Creative Bioarray Revenue in GPCR Screening Service Business (2021-2026)
- 12.11.4 Creative Bioarray GPCR Screening Service Product Portfolio
- 12.11.5 Creative Bioarray Recent Developments
- 12.12 ICE Bioscience
- 12.12.1 ICE Bioscience Company Information
- 12.12.2 ICE Bioscience Business Overview
- 12.12.3 ICE Bioscience Revenue in GPCR Screening Service Business (2021-2026)
- 12.12.4 ICE Bioscience GPCR Screening Service Product Portfolio
- 12.12.5 ICE Bioscience Recent Developments
- 12.13 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd.
- 12.13.1 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Company Information
- 12.13.2 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Business Overview
- 12.13.3 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026)
- 12.13.4 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. GPCR Screening Service Product Portfolio
- 12.13.5 Shanghai Jinsirui Vigorous Biotechnology Co., Ltd. Recent Developments
- 12.14 Promega Corporation
- 12.14.1 Promega Corporation Company Information
- 12.14.2 Promega Corporation Business Overview
- 12.14.3 Promega Corporation Revenue in GPCR Screening Service Business (2021-2026)
- 12.14.4 Promega Corporation GPCR Screening Service Product Portfolio
- 12.14.5 Promega Corporation Recent Developments
- 12.15 Proteros biostructures GmbH
- 12.15.1 Proteros biostructures GmbH Company Information
- 12.15.2 Proteros biostructures GmbH Business Overview
- 12.15.3 Proteros biostructures GmbH Revenue in GPCR Screening Service Business (2021-2026)
- 12.15.4 Proteros biostructures GmbH GPCR Screening Service Product Portfolio
- 12.15.5 Proteros biostructures GmbH Recent Developments
- 12.16 Aragen Life Sciences
- 12.16.1 Aragen Life Sciences Company Information
- 12.16.2 Aragen Life Sciences Business Overview
- 12.16.3 Aragen Life Sciences Revenue in GPCR Screening Service Business (2021-2026)
- 12.16.4 Aragen Life Sciences GPCR Screening Service Product Portfolio
- 12.16.5 Aragen Life Sciences Recent Developments
- 12.17 BPS Bioscience, Inc.
- 12.17.1 BPS Bioscience, Inc. Company Information
- 12.17.2 BPS Bioscience, Inc. Business Overview
- 12.17.3 BPS Bioscience, Inc. Revenue in GPCR Screening Service Business (2021-2026)
- 12.17.4 BPS Bioscience, Inc. GPCR Screening Service Product Portfolio
- 12.17.5 BPS Bioscience, Inc. Recent Developments
- 12.18 Revvity, Inc.
- 12.18.1 Revvity, Inc. Company Information
- 12.18.2 Revvity, Inc. Business Overview
- 12.18.3 Revvity, Inc. Revenue in GPCR Screening Service Business (2021-2026)
- 12.18.4 Revvity, Inc. GPCR Screening Service Product Portfolio
- 12.18.5 Revvity, Inc. Recent Developments
- 12.19 Genscript Biotech Corporation
- 12.19.1 Genscript Biotech Corporation Company Information
- 12.19.2 Genscript Biotech Corporation Business Overview
- 12.19.3 Genscript Biotech Corporation Revenue in GPCR Screening Service Business (2021-2026)
- 12.19.4 Genscript Biotech Corporation GPCR Screening Service Product Portfolio
- 12.19.5 Genscript Biotech Corporation Recent Developments
- 12.20 Beijing Abace Biotechnology Co., Ltd.
- 12.20.1 Beijing Abace Biotechnology Co., Ltd. Company Information
- 12.20.2 Beijing Abace Biotechnology Co., Ltd. Business Overview
- 12.20.3 Beijing Abace Biotechnology Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026)
- 12.20.4 Beijing Abace Biotechnology Co., Ltd. GPCR Screening Service Product Portfolio
- 12.20.5 Beijing Abace Biotechnology Co., Ltd. Recent Developments
- 12.21 MedChemExpress LLC
- 12.21.1 MedChemExpress LLC Company Information
- 12.21.2 MedChemExpress LLC Business Overview
- 12.21.3 MedChemExpress LLC Revenue in GPCR Screening Service Business (2021-2026)
- 12.21.4 MedChemExpress LLC GPCR Screening Service Product Portfolio
- 12.21.5 MedChemExpress LLC Recent Developments
- 12.22 BrainVTA (Wuhan) Co., Ltd.
- 12.22.1 BrainVTA (Wuhan) Co., Ltd. Company Information
- 12.22.2 BrainVTA (Wuhan) Co., Ltd. Business Overview
- 12.22.3 BrainVTA (Wuhan) Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026)
- 12.22.4 BrainVTA (Wuhan) Co., Ltd. GPCR Screening Service Product Portfolio
- 12.22.5 BrainVTA (Wuhan) Co., Ltd. Recent Developments
- 12.23 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd.
- 12.23.1 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Company Information
- 12.23.2 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Business Overview
- 12.23.3 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Revenue in GPCR Screening Service Business (2021-2026)
- 12.23.4 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. GPCR Screening Service Product Portfolio
- 12.23.5 Genevoyager Biopharmaceutical Technology (Wuhan) Co., Ltd. Recent Developments
- 12.24 Penn State GPCR Assay Service Center
- 12.24.1 Penn State GPCR Assay Service Center Company Information
- 12.24.2 Penn State GPCR Assay Service Center Business Overview
- 12.24.3 Penn State GPCR Assay Service Center Revenue in GPCR Screening Service Business (2021-2026)
- 12.24.4 Penn State GPCR Assay Service Center GPCR Screening Service Product Portfolio
- 12.24.5 Penn State GPCR Assay Service Center Recent Developments
- 12.25 Celtarys Research
- 12.25.1 Celtarys Research Company Information
- 12.25.2 Celtarys Research Business Overview
- 12.25.3 Celtarys Research Revenue in GPCR Screening Service Business (2021-2026)
- 12.25.4 Celtarys Research GPCR Screening Service Product Portfolio
- 12.25.5 Celtarys Research Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst